Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

Kitko, CL; Arora, M; DeFilipp, Z; Abu Zaid, M; Di Stasi, A; Radojcic, V; Betts, CB; Coussens, LM; Meyers, ML; Qamoos, H; Ordentlich, P; Kumar, V; Quaranto, C; Schmitt, A; Gu, Y; Blazar, BR; Wang, TP; Salhotra, A; Pusic, I; Jagasia, M; Lee, SJ

Kitko, CL (通讯作者)，Vanderbilt Univ, Med Ctr, 2220 Pierce Ave 386 PRB, Nashville, TN 37232 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (10): 1864

Abstract

PURPOSE Chronic graft-versus-host disease (cGVHD) remains the major cause of late morbidity after allogeneic hematopoietic cell transplantation. Colon......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索